The global market for ENT balloon dilation devices had a valuation of $933 million in 2022, and it is expected to grow at a CAGR of 3.9% during the forecast period, reaching $1.2 billion. The comprehensive report focuses on the balloon sets and excludes the extended set of the market.
Acclarent was the pioneer competitor in the market for balloon sinus dilation (BSD) devices with the launch of its Relieva® Balloon Sinuplasty system. Acclarent's acquisition by Johnson & Johnson in 2010 provided the company with the necessary sales and marketing resources to compete in this rapidly expanding market. Acclarent owes much of its current success to its early entry into this market and its affiliation with Johnson & Johnson.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL ENT BALLOON DILATION DEVICE MARKET INSIGHTS
The one-sitting, minimally invasive nature of the procedure is a significant driver of the ENT balloon dilation device market. Patients typically experience minimal bleeding and can return to their normal routine within a few hours, making the procedure highly appealing. As a result, these devices have gained popularity worldwide.GLOBAL ENT BALLOON DILATION DEVICE MARKET SHARE INSIGHTS
The Global ENT balloon dilation device market was led by Acclarent, Stryker, and Medtronic.Acclarent was the pioneer competitor in the market for balloon sinus dilation (BSD) devices with the launch of its Relieva® Balloon Sinuplasty system. Acclarent's acquisition by Johnson & Johnson in 2010 provided the company with the necessary sales and marketing resources to compete in this rapidly expanding market. Acclarent owes much of its current success to its early entry into this market and its affiliation with Johnson & Johnson.
MARKET SEGMENTATION SUMMARY
ENT Balloon Dilation Device Market - MedCore - Includes:- Balloon Sets
RESEARCH SCOPE SUMMARY
- Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
- Base Year: 2022
- Forecast Period: 2023-2029
- Historical Data: 2019-2022
- Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
- Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
- Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Table of Contents
Balloon Dilation Device Market- Introduction
- Market Analysis and Forecast
- Drivers and Limiters
- Market Drivers
- Market Limiters
- Competitive Market Share Analysis
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acclarent
- Stryker
- Medtronic
- Smith & Nephew
